SeLux Diagnostics

SeLux Diagnostics

Verified
SeLux Diagnostics is developing universal synthetic amplifier technology equipment for antibiotic susceptibility testing and diagnostics

Launch date
Employees
Ownership
Market cap
-
Net debt
-
Firm valuation
$200—300m (Dealroom.co estimates Feb 2022.)
Charlestown New Hampshire (HQ)
  • Edit
DateInvestorsAmountRound
$23.5mLate VC
$25mSeries B
N/AN/ASeries B
Not yet verified
N/A$9.6mGrant
Not yet verified
N/A$2.5mDebt
$14.6mGrant
*
$50mSeries C
*
$30mDebt
*
$8mGrant
Total Funding$121m

Recent News about SeLux Diagnostics

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.